Cargando…
(3-Carboxy-5-sulfonatobenzoato-κ(2) O (1),O (1′))bis[2-(2-pyridyl)-1H-benzimidazole-κ(2) N (2),N (3)]zinc(II) monohydrate
In the title compound, [Zn(C(8)H(4)O(7)S)(C(12)H(9)N(3))(2)]·H(2)O, the Zn(II) atom has a distorted octahedral coordination geometry, defined by four N atoms from two 2-(2-pyridyl)-1H-benzimidazole ligands and two O atoms from a deprotonated carboxylate group of the 3-carboxy-5-sulfonatobenzoate...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968999/ https://www.ncbi.nlm.nih.gov/pubmed/21582356 http://dx.doi.org/10.1107/S1600536809009180 |
Sumario: | In the title compound, [Zn(C(8)H(4)O(7)S)(C(12)H(9)N(3))(2)]·H(2)O, the Zn(II) atom has a distorted octahedral coordination geometry, defined by four N atoms from two 2-(2-pyridyl)-1H-benzimidazole ligands and two O atoms from a deprotonated carboxylate group of the 3-carboxy-5-sulfonatobenzoate ligand. In the crystal structure, the complex molecules are linked into a three-dimensional network by intermolecular O—H⋯O and N—H⋯O hydrogen bonds, and π–π stacking interactions with centroid–centroid separations of 3.758 (2) and 3.597 (1) Å. |
---|